Vanguard Group’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-51,741
Closed -$174K 4589
2022
Q4
$174K Sell
51,741
-193,344
-79% -$531K ﹤0.01% 4331
2022
Q3
$575K Sell
245,085
-298,778
-55% -$1.01M ﹤0.01% 4175
2022
Q2
$2.77M Sell
543,863
-19,440
-3% -$99.8K ﹤0.01% 3666
2022
Q1
$3.7M Sell
563,303
-2,445
-0.4% -$26.8K ﹤0.01% 3670
2021
Q4
$10.4M Buy
565,748
+8,082
+1% +$268K ﹤0.01% 3181
2021
Q3
$23.2M Buy
+557,666
New +$25.7M ﹤0.01% 2779

Other funds holding GTH

Vanguard Group's GTH Position: Q1 2023 in Review

Vanguard Group sold out of Genetron Holdings Limited ADS (GTH) in Q1 2023, closing a stake of 51,741 shares — an estimated $174K sold.

Vanguard Group first reported a position in GTH in Q3 2021 and held it in 6 quarters. The position peaked at $23.2M in Q3 2021. 18 funds tracked by Wall St. Rank hold GTH as of Q1 2023.

  • Vanguard Group reported no remaining Genetron Holdings Limited ADS position as of Q1 2023 after selling out during the quarter.
  • Vanguard Group sold 51,741 Genetron Holdings Limited ADS shares in Q1 2023, an estimated $174K.
  • Vanguard Group first reported a position in Genetron Holdings Limited ADS in Q3 2021 and held it in 6 quarters.
  • Vanguard Group's Genetron Holdings Limited ADS position peaked at $23.2M in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q1 2023.

Based on Vanguard Group's 13F filing for Q1 2023, filed 15 May 2023.